Patent · US Active

Attenuated influenza viruses and vaccines

US10316294B2 · kind B2 · utility

3Cited by

1References

13Claims

0Family size

Assignee

The Research Foundation for The State University of New York · US

Inventors

Steffen Mueller · Pforzheim, DE
Eckard Wimmer · Port Jefferson, US
Bruce Futcher · Stony Brook, US
Steven Skiena · Albany, US
Chen Yang · Elmont, US

Key dates

Filing date	Mar 15, 2014
Grant date	Jun 11, 2019
Priority date	—
Expiry date	Mar 15, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16162
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides highly attenuated influenza viruses and vaccines. The attenuated viruses and vaccines proliferate well and have high safety factors. The attenuated viruses providing protective immunity from challenge by virus of the same subtype, as well as cross protection against heterologous viruses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.